Objective Using gene chip technology to explore the molecular mechanism of euphorbiasteroid in the treatment of non-small cell lung cancer(NSCLC).Methods A549 cells were used as the in vitro model,and they were random...Objective Using gene chip technology to explore the molecular mechanism of euphorbiasteroid in the treatment of non-small cell lung cancer(NSCLC).Methods A549 cells were used as the in vitro model,and they were randomly divided into control group and different concentrations of euphorbiasteroid administration groups.Each group had 3 duplicate wells,after the cells were cultured in vitro,the cell viability was evaluated by CCK-8 method.Gene chip technology was used to screen the differentially expressed genes(DEGs)between the control group and the euphorbiasteroid administration group.The differential genes were further analyzed for Gene Ontology(GO)function enrichment and Kyoto Encyclopedia of Genes and Genome(KEGG)pathway enrichment analysis.The STRING online analysis platform combined with Cytoscape software to construct a target protein interaction(PPI)network and perform topological analysis to screen key targets,and use Real-time PCR(RT-PCR)and molecular docking technology to verify key targets.Results According to the analysis of gene chip data,276 differentially expressed genes were screened,including 117 up-regulated genes and 159 down-regulated genes.GO analysis showed that differentially expressed genes were mainly involved in cell division,cell proliferation,cell cycle and other processes,involving protein binding,protein kinase binding and other functions,and were mainly distributed in nucleoplasm,chromosomes and other parts.KEGG signaling pathway analysis showed that differentially expressed genes were involved in cell cycle,pyrimidine metabolism,p53 signaling pathway and other pathways.PPI network analysis showed that CCNA2,TOP2A,CCNB1,CDC20,and RRM2 may be the key targets of euphorbiasteroid in the treatment of NSCLC.RT-PCR results showed that the expressions of CCNA2,TOP2A,CCNB1,CDC20,and RRM2 were significantly down-regulated in the euphorbiasteroid administered group,which was consistent with the gene chip results.Molecular docking results showed that euphorbiasteroid had good affinity with key targets and could bind spontaneously and stably.Conclusion The combination of gene chip,RT-PCR technology and molecular docking technology can find out the differential genes after the intervention of euphorbiasteroid,which can be used to explore the mechanism of euphorbiasteroid in the treatment of NSCLC.展开更多
目的基于网络药理学和分子对接技术探讨千金子引发腹泻的作用机制。方法通过TCMSP数据库收集千金子化学成分信息,在PubChem、SwissTargetPrediction和GeneCards等数据库收集其化学成分作用靶点及腹泻相关靶点,利用DAVID数据库对千金子...目的基于网络药理学和分子对接技术探讨千金子引发腹泻的作用机制。方法通过TCMSP数据库收集千金子化学成分信息,在PubChem、SwissTargetPrediction和GeneCards等数据库收集其化学成分作用靶点及腹泻相关靶点,利用DAVID数据库对千金子与腹泻的共有靶点进行基因本体(gene ontology,GO)功能富集及京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)通路富集;使用Cytoscape软件构建PPI网络图及“活性成分-靶点-疾病”网络,筛选出主要活性成分与核心靶点进行分子对接。培养人结肠癌细胞系HCT116,采用实时荧光定量PCR(real time quantitative PCR,RT-qPCR)验证计算模拟结果。结果经筛选得到千金子潜在活性成分12个及其对应靶点389个,腹泻相关靶点570个,二者共同靶点43个。GO功能富集分析发现共同靶点主要参与ATP结合和ERBB2信号传导途径等生物过程,KEGG信号通路分析发现千金子主要影响Rap1信号通路、PI3K-AKT信号通路、Ras信号通路、ERBB信号通路、HIF-1信号通路、HTLV-I感染和FoxO信号通路。分子对接结果显示,各活性成分与SRC、PIK3CA、AKT1和PIK3R1等靶点结合良好。千金子甾醇可抑制细胞活性,使EGFR和mTOR基因表达异常。结论千金子可能通过beta-sitosterol、stigmasterol、artemetin和euphorbiasteroid等关键活性成分作用于SRC、PIK3CA、AKT1和PIK3R1等靶点和通路,从而引发腹泻。展开更多
基金This study was supported by the National Key Research and Development Program of China(Grant No.2018YFE0197900).
文摘Objective Using gene chip technology to explore the molecular mechanism of euphorbiasteroid in the treatment of non-small cell lung cancer(NSCLC).Methods A549 cells were used as the in vitro model,and they were randomly divided into control group and different concentrations of euphorbiasteroid administration groups.Each group had 3 duplicate wells,after the cells were cultured in vitro,the cell viability was evaluated by CCK-8 method.Gene chip technology was used to screen the differentially expressed genes(DEGs)between the control group and the euphorbiasteroid administration group.The differential genes were further analyzed for Gene Ontology(GO)function enrichment and Kyoto Encyclopedia of Genes and Genome(KEGG)pathway enrichment analysis.The STRING online analysis platform combined with Cytoscape software to construct a target protein interaction(PPI)network and perform topological analysis to screen key targets,and use Real-time PCR(RT-PCR)and molecular docking technology to verify key targets.Results According to the analysis of gene chip data,276 differentially expressed genes were screened,including 117 up-regulated genes and 159 down-regulated genes.GO analysis showed that differentially expressed genes were mainly involved in cell division,cell proliferation,cell cycle and other processes,involving protein binding,protein kinase binding and other functions,and were mainly distributed in nucleoplasm,chromosomes and other parts.KEGG signaling pathway analysis showed that differentially expressed genes were involved in cell cycle,pyrimidine metabolism,p53 signaling pathway and other pathways.PPI network analysis showed that CCNA2,TOP2A,CCNB1,CDC20,and RRM2 may be the key targets of euphorbiasteroid in the treatment of NSCLC.RT-PCR results showed that the expressions of CCNA2,TOP2A,CCNB1,CDC20,and RRM2 were significantly down-regulated in the euphorbiasteroid administered group,which was consistent with the gene chip results.Molecular docking results showed that euphorbiasteroid had good affinity with key targets and could bind spontaneously and stably.Conclusion The combination of gene chip,RT-PCR technology and molecular docking technology can find out the differential genes after the intervention of euphorbiasteroid,which can be used to explore the mechanism of euphorbiasteroid in the treatment of NSCLC.
文摘目的基于网络药理学和分子对接技术探讨千金子引发腹泻的作用机制。方法通过TCMSP数据库收集千金子化学成分信息,在PubChem、SwissTargetPrediction和GeneCards等数据库收集其化学成分作用靶点及腹泻相关靶点,利用DAVID数据库对千金子与腹泻的共有靶点进行基因本体(gene ontology,GO)功能富集及京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)通路富集;使用Cytoscape软件构建PPI网络图及“活性成分-靶点-疾病”网络,筛选出主要活性成分与核心靶点进行分子对接。培养人结肠癌细胞系HCT116,采用实时荧光定量PCR(real time quantitative PCR,RT-qPCR)验证计算模拟结果。结果经筛选得到千金子潜在活性成分12个及其对应靶点389个,腹泻相关靶点570个,二者共同靶点43个。GO功能富集分析发现共同靶点主要参与ATP结合和ERBB2信号传导途径等生物过程,KEGG信号通路分析发现千金子主要影响Rap1信号通路、PI3K-AKT信号通路、Ras信号通路、ERBB信号通路、HIF-1信号通路、HTLV-I感染和FoxO信号通路。分子对接结果显示,各活性成分与SRC、PIK3CA、AKT1和PIK3R1等靶点结合良好。千金子甾醇可抑制细胞活性,使EGFR和mTOR基因表达异常。结论千金子可能通过beta-sitosterol、stigmasterol、artemetin和euphorbiasteroid等关键活性成分作用于SRC、PIK3CA、AKT1和PIK3R1等靶点和通路,从而引发腹泻。